Product Information
OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Elite Laboratories, Inc., priced at $0.1171 per EA under NDC 64850062101. Its NADAC has been published 65 times since Jul 9, 2025.
FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 5 mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850062101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209385FDA Approved
7/2/2018
TE Code
AA
On Market Since
12/4/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 65 times since Jul 9, 2025, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1171 per EA |
|---|---|
| All-time high | $0.1233 (Jul 16, 2025) |
| All-time low | $0.1171 (Sep 23, 2026) |
| 52-week high | $0.1228 |
| 52-week low | $0.1171 |
| Median price | $0.1195 |
| Average price | $0.1200 |
| Largest weekly change | -2.1% (Sep 23, 2026) |
| Weeks tracked | 65 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Oxycodone Hydrochloride and Acetaminophen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Elite Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone Hydrochloride and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Elite Laboratories, Inc., is $0.1171 per EA (NDC 64850062101), effective Sep 30, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has declined 5.1%. It has been tracked across 65 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Since Jul 9, 2025, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.1171 (Sep 23, 2026) to a high of $0.1233 (Jul 16, 2025), with a median of $0.1195 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 64850062101) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.